Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...
Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday ...
Eli Lilly and Alchemab Therapeutics have partnered to develop new therapies for amyotrophic lateral sclerosis (ALS). The ...
Hosted on MSN10mon
Eli Lilly's Legal Battle Against Fake Compounded Tirzepatide Products: Bacteria, Impurities DetectedWhile the United States permits licensed pharmacies to produce compounded drugs legally during shortages of the branded version, Eli Lilly clarified ... impurities in some samples of compounded ...
GlobalData on MSN2d
Eli Lilly targets Scorpion Therapeutics to expand reach in oncologyAfter selling its PI3Kα program to Eli Lilly, Scorpion will spinout out a different entity, which will be owned by the biotech’s current shareholders.
The UK biopharma company Alchemab Therapeutics announced today that it has joined forces with Eli Lilly to discover, develop, ...
Alchemab Therapeutics, a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback